Clinical Trials Logo

Filter by:
NCT ID: NCT03038100 Completed - Ovarian Cancer Clinical Trials

A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

IMagyn050
Start date: March 8, 2017
Phase: Phase 3
Study type: Interventional

This is a Phase III, global, double-blind, 2-arm randomized study designed to compare the efficacy and safety of atezolizumab + paclitaxel + carboplatin + bevacizumab versus placebo + paclitaxel + carboplatin + bevacizumab. Study participants will have Stage 3 or 4 ovarian cancer (OC), fallopian tube cancer (FTC), or primary peritoneal cancer (PPC) with macroscopic residual disease postoperatively (i.e., after primary tumor reductive surgery) or who will undergo neoadjuvant therapy followed by interval surgery.

NCT ID: NCT03038022 Completed - Clinical trials for Heterozygous Familial Hypercholesterolemia

Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)

Start date: February 9, 2017
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to determine the effect of once-daily oral MGL-3196 on the percent change from baseline in low-density lipoprotein cholesterol (LDL-C) in patients with Heterozygous Familial Hypercholesterolemia (HeFH).

NCT ID: NCT03036917 Completed - Clinical trials for Cognitive Impairment

Cognitive Function Before and After Opioid Reduction in Patients With Chronic Pain

coffee-cup
Start date: January 1, 2018
Phase:
Study type: Observational

This study aims to investigate the cognitive function of patients in the opioid reduction programme at the multidisciplinary pain centre at Zealand University Hospital Køge. The patients will be tested before, halfway through, and after the programme.

NCT ID: NCT03036748 Completed - Clinical trials for Kidney Transplant; Complications

Increased Activity of ENaC in Proteinuric Kidney Transplant Recipients

Start date: January 1, 2017
Phase: N/A
Study type: Interventional

The aim of this study is to determine if amiloride, a diuretic drug, is capable of increasing renal salt excretion, lowering blood pressure and inhibiting uPA in kidney transplant recipients with proteinuria compared to normoalbuminuric transplant patients.

NCT ID: NCT03036150 Completed - Clinical trials for Chronic Kidney Disease

A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease

Dapa-CKD
Start date: February 2, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effect of dapagliflozin on renal outcomes and cardiovascular mortality in patients with chronic kidney disease.

NCT ID: NCT03036124 Completed - Clinical trials for Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)

Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure

DAPA-HF
Start date: February 8, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the effect of dapagliflozin on the incidence of worsening heart failure or cardiovascular death in patients with chronic heart failure with reduced ejection fraction

NCT ID: NCT03035539 Completed - Atrial Fibrillation Clinical Trials

Rehabilitation of Patients With Atrial Fibrillation

Start date: May 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether a rehabilitation programme can improve the quality of life and reduce morbidity in patients with atrial fibrillation. In addition, the study will map the economic costs and benefits of such a rehabilitation programme.

NCT ID: NCT03034590 Completed - Stroke Clinical Trials

How to Identify Fatigue in Stroke Patients

Start date: August 2014
Phase: N/A
Study type: Observational

This study will translate an English case definition of poststroke fatigue and validate it against the Multidimensional Fatigue Questionnaire-20 and the Fatigue Severity Scale

NCT ID: NCT03034239 Completed - Clinical trials for Protein Supplementation

The Effect of Insect Protein on Performance and Hypertrophy

Start date: March 20, 2017
Phase: N/A
Study type: Interventional

Purpose: to study the effect of insect protein on performance and hypertrophy during 8 weeks of resistance training. Hypothesis: Insect protein supplementation enhances the effect of resistance training on muscle mass and muscle strength. Primary outcome: Muscle hypertrophy and muscle strength Design: Two groups of healthy young men (age: 18-30 years) with resistance training experience, but no structural resistance training performed for the last 12 months. Randomized controlled intervention study +/- insect protein (placebo group ingest isocaloric carbohydrate). Both groups perform 8 weeks of progressive resistance training (4/week) aiming to induce muscle hypertrophy.

NCT ID: NCT03034226 Completed - Clinical trials for Diabetes Mellitus, Type 1

Comparison Between Hypoglycemic Counter Regulatory Responses in Type 1 Diabetics vs Control Subjects

Start date: February 23, 2017
Phase: N/A
Study type: Interventional

This study compares the hypoglycemic counter regulatory response in type 1 diabetics and in healthy control subjects with and without antecedent hypoglycemia